Company Intelligence Profile

Indo Riv Clinical Private Limited

Kolkata-based hybrid biotechnology CRO combining human biospecimen biobanking with clinical trial services, operating under the legal entity Indo Riv Clinical Private Limited (CIN U05004WB1990PTC050110).

CIN: U05004WB1990PTC050110ActiveRegistrar of Companies, KolkataConfidence: medium

Last updated 17 August 2026

AI OverviewGenerated from public records

AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.

See what AICA knows about Indo Riv Clinical

Deeper analysis, financial signals and peer comparisons.

Book a demo

Company Identity

Confirmed
Registered nameIndo Riv Clinical Private Limited
CINU05004WB1990PTC050110
PANAABCI6013R (derived from GSTIN 19AABCI6013R1Z6 per standard GSTIN structure; not independently confirmed on a PAN-verification source)
StatusActive
ListingUnlisted / not listed on any stock exchange
Incorporated05 Nov 1990 per Tofler direct fetch (one other aggregator snippet said "05 Dec 1990" — minor date discrepancy across sources, RoC filing not independently verified)
ROCRegistrar of Companies, Kolkata
Sector (NIC)NIC 050 — Agriculture and Allied Activities
Registered address44 G, Paddapukur Road, Ballygunge/Bhawanipore, Kolkata, West Bengal - 700025
Authorized capitalINR 50.0 Lac
Paid-up capitalINR 14.0 Lac

Business Overview

Confirmed
  • Operates as "Indoriv Clinical" — a hybrid biotechnology CRO (Contract Research Organization) based in Kolkata, combining human biospecimen biobanking with prospective clinical trial services, primarily serving cancer/oncology research
  • Offers clinical project management, data generation, diagnostic/pathology lab services, clinical trial medical supply, and an "MPET" digitization platform
  • Founded in 2012 by Anant Agarwal (reportedly with Akriti Dokania and Prateek Agarwal per one source), operating under the legal entity Indo Riv Clinical Private Limited (CIN incorporated 1990 — appears to be a pre-existing corporate shell repurposed for the current CRO/biobank business, consistent with the mismatched legacy "agriculture" NIC code)
  • Cited clients (2016 article) include Biocon, Sun Pharmaceuticals, Syngene, Dr Reddy's. Won India 5000 Best MSME Award 2023

Directors

Partial / conflicting
NameDINRoleAppointed
Ravi Kumar Agarwal00574439--

GST Registration

Confirmed
GSTINStatePANStatus
19AABCI6013R1Z6West BengalAABCI6013R (derived from GSTIN 19AABCI6013R1Z6 per standard GSTIN structure; not independently confirmed on a PAN-verification source)Active

Primary GSTIN: 19AABCI6013R1Z6 (state code 19 = West Bengal), legal name "INDO RIV CLINICAL PRIVATE LIMITED", registered 26 Jul 2017, status Active, constitution Private Limited Company, registration type Regular, nature of business "Supplier of Services, Retail Business", jurisdiction BEHALA WB034, principal place of business "38 Block-B, 54 Shibnath Shastri Sarani, New Alipore, Kolkata - 700053" (per Know Your GST — this differs from the registered corporate address, i.e. separate GST place-of-business vs. RoC registered office). Only one GSTIN identified; #registrations across states not obtained.

Financials

Partial / conflicting
  • FY ending March 2025: Revenue in the INR 10-25 crore band, up 53.49% YoY. EBITDA, PAT, net worth and borrowings figures are behind Tofler's paywall ("data restricted") but directional YoY changes given: EBITDA +35.47%, Net Profit +80.78%, Net Worth +70.97%, Borrowings -12.67%
  • No independently sourced absolute figures obtained
  • Last AGM per Tofler: 30 Sep 2023 (one search snippet said 30 Dec 2023 — minor conflict)

Funding

Partial / conflicting
  • No institutional/VC funding identified
  • A 2016 BioSpectrum India feature quotes founder Anant Agarwal saying the company was bootstrapped via project cash flow in its early years and was "currently looking to raise funds actively" at that time for expansion (MPET platform, target revenue growth to Rs 30-40 crore)
  • No subsequent funding round found on Crunchbase/Tracxn snippets as of this research (2026) — Tracxn/Crunchbase profiles exist but no round data surfaced
  • Treat funding status as likely still self-funded, but this is based on a 10-year-old statement and could be stale

Charges / Loans

Partial / conflicting
  • charge with Ashika Global Finance Private Limited, INR 0.4 crore, created 24 Nov 2023 (status/satisfaction not specified)
  • Charge with Union Bank of India, INR 0.2 crore, created 07 Sep 2022
  • Only these two charges identified; no independent confirmation from a second source

Competitors

Partial / conflicting
CliniRx
established CRO, oncology/infectious disease focus, larger/more established scale
Croissance Clinical Research
CRO, preclinical/clinical support, similar small-mid scale
Genelife Clinical Research
CRO for pharma/biotech/medical device clients, similar scale

Frequently Asked Questions

What does Indo Riv Clinical Private Limited do?
Kolkata-based hybrid biotechnology CRO combining human biospecimen biobanking with clinical trial services, operating under the legal entity Indo Riv Clinical Private Limited (CIN U05004WB1990PTC050110).
What is the CIN of Indo Riv Clinical Private Limited?
The Corporate Identification Number (CIN) of Indo Riv Clinical Private Limited is U05004WB1990PTC050110.
Where is Indo Riv Clinical Private Limited registered?
Indo Riv Clinical Private Limited is registered with Registrar of Companies, Kolkata. Registered address: 44 G, Paddapukur Road, Ballygunge/Bhawanipore, Kolkata, West Bengal - 700025 (Tofler; matches official site contact address)
When was Indo Riv Clinical Private Limited incorporated?
Indo Riv Clinical Private Limited was incorporated on 05 Nov 1990 per Tofler direct fetch (one other aggregator snippet said "05 Dec 1990" — minor date discrepancy across sources, RoC filing not independently veri….

Explore on Recur Club

Bharat Ke Super Founders

Recur Club's show spotlighting the founders building India's next generation of companies. Watch their stories.

Watch the show

Looking for business funding?

Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.

Disclaimer: Company information shown on this page is compiled from public records and third-party sources. It may be incomplete, outdated, or contain inaccuracies, and is provided for general informational purposes only. Please verify details independently before relying on them.